Cataract Surgery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Cataract Surgery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Cataract Surgery Devices Market by Product Type (Phacoemulsification Systems, Femtosecond Lasers, Intraocular Lenses, Ophthalmic Viscosurgical Devices, and Others), End-User (Hospitals and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to growing prevalence of cataract and increasing geriatric population.

The cataract surgery devices market was valued at USD 7.73 billion in 2023, growing at a CAGR of 5.50% during the forecast period from 2024 to 2030 to reach USD 10.66 billion by 2030. The demand for cataract surgery devices is primarily being boosted by the growing prevalence of cataracts and vision impairment and the increasing prevalence of lifestyle disorders that develop cataracts such as hypertension and diabetes. The rising geriatric population and R&D activities and technological innovation in product development are some of the other key factors that are responsible for contributing to the positive growth of the cataract surgery devices market during the forecast period from 2024 to 2030.

Cataract Surgery Devices Market Dynamics:

The rising prevalence of cataracts and vision impairment is significantly contributing to the growth of the cataract surgery devices market. According to the World Health Organization (WHO), in 2023, over 2.2 billion people globally were affected by near or distance vision impairment. In England alone, as per data published by the Government of the United Kingdom in May 2024, more than 516,073 people were admitted to hospitals for cataract surgery in 2023. Cataract surgery devices help address this issue by either fragmenting and removing the cloudy lens or by implanting an artificial intraocular lens (IOL) after cataract removal. As a result, the growing incidence of cataracts and vision impairment is expected to drive significant market growth for these surgical devices.

Aging is the primary risk factor for cataracts, which typically develop due to age-related macular degeneration, especially after age 60. Data provided by the National Institute of Health (NIH) in November 2023 revealed that over 50% of individuals aged 80 and above either had cataracts or had undergone cataract surgery in the United States in 2023. Moreover, WHO’s 2022 report projected that the global population aged 60 and above will double from 12% to 22% between 2015 and 2050, reaching 2.1 billion by 2050. By 2030, one in six individuals will be aged 60 or older. Since cataracts occur predominantly in older people, this demographic shift is expected to increase the demand for cataract surgeries and, consequently, drive the demand for cataract surgery devices, boosting market growth.

Lifestyle disorders, particularly diabetes and hypertension, also contribute to the development of cataracts. High blood sugar levels associated with diabetes cause structural changes in the eye’s lens, accelerating cataract formation. According to data from the International Diabetes Federation (IDF) in 2023, approximately 537 million adults aged 20 to 79 were living with diabetes in 2021. This number is projected to rise to 643 million by 2030 and 783 million by 2045. Diabetes is a major risk factor for cataracts, as it impacts various ocular structures, making cataracts a common complication of the condition. Therefore, the increasing prevalence of diabetes and other lifestyle-related diseases is expected to further drive market growth.

Key players in the cataract surgery market are focusing their research and development (R&D) efforts on creating advanced solutions to improve surgical precision and patient outcomes. For example, in January 2021, Alcon launched the AcrySof® IQ Vivity™ IOL in the United States. Vivity is a non-diffractive extended depth-of-focus intraocular lens based on X-WAVE™ technology, offering monofocal-quality distance vision along with enhanced intermediate and functional near vision, thus providing a comprehensive visual experience without light splitting. Such product innovations by leading companies are expected to fuel market growth.

However, complications associated with cataract surgery and the limited availability of these devices in developing countries may pose challenges to the growth of the cataract surgery devices market.

Cataract Surgery Devices Market Segment Analysis:

Cataract Surgery Devices Market by Product Type (Phacoemulsification Systems, Femtosecond Lasers, Intraocular Lenses, Ophthalmic Viscosurgical Devices, and Others), End-User (Hospitals and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the cataract surgery devices market, femtosecond lasers are expected to account for a significant share during the forecast period, driven by the increasing number of cataract surgeries performed globally. According to data from the European Commission in 2023, cataract surgery was the most commonly performed surgical procedure, with 4.32 million surgeries conducted across Europe in 2021. Femtosecond lasers enhance cataract surgery by performing key tasks such as capsulorrhexis (the opening of the lens capsule) and fragmenting the lens, thus facilitating its removal and improving the efficiency of the procedure.

The growing adoption of laser-assisted cataract surgery over conventional methods is attributed to the many benefits femtosecond lasers offer. This advanced technique minimizes damage to surrounding tissues and reduces the risk of complications such as ectasia. Laser-assisted cataract surgery, which utilizes computer-guided, bladeless operations, ensures greater precision, resulting in more accurate incisions compared to traditional corneal methods. The increased precision and reduced risk contribute to its growing popularity in the field of cataract surgery.

Femtosecond lasers provide a high degree of precision and consistency when creating incisions in the cornea and lens capsule, leading to improved procedural outcomes and fewer complications. This technique not only accelerates the healing process but also offers the added benefit of astigmatism correction in cataract patients. These advantages are expected to drive demand for laser-assisted cataract surgery devices, thereby fueling market growth during the forecast period.

Leading players in the market are focusing on the development and commercialization of advanced femtosecond lasers to improve surgical precision, safety, and patient outcomes. For instance, in April 2023, Johnson & Johnson MedTech received FDA 510(k) clearance for their ELITA Femtosecond Laser system. The ELITA system is designed with low energy per pulse and an ultra-fast laser repetition rate to minimize complications and enhance both visual recovery and patient outcomes. Such innovations are expected to drive significant growth in the femtosecond laser segment, contributing to the overall expansion of the cataract surgery devices market.

North America is expected to dominate the overall cataract surgery devices market:

North America is expected to hold the largest share of the cataract surgery devices market in 2023, driven by the rising prevalence of cataracts and vision impairments, alongside increasing risk factors such as diabetes, hypertension, and obesity in the region. The growing aging population, which is more susceptible to developing cataracts, and technological innovations in product development further contribute to the market's expansion in North America.

According to data from the Centers for Disease Control and Prevention (CDC) in May 2024, an estimated 20.5 million individuals aged 40 and older in the United States were affected by cataracts in one or both eyes in 2022. This number is projected to rise in the coming years, creating increased demand for cataract removal treatments and driving growth in the cataract surgery devices market.

Additionally, the rising rates of obesity and overweight individuals in North America are contributing to the demand for cataract surgery devices. Obesity is linked to systemic inflammation, which can promote cataract development. According to data from the Government of Canada in May 2024, one in every three Canadians was considered obese in 2022. The increasing prevalence of such risk factors, which are associated with cataract formation, is expected to further fuel market growth in the region.

Key players in the cataract surgery devices market are investing in research and development to create and commercialize advanced solutions, thereby boosting market growth. For instance, in May 2021, Johnson & Johnson MedTech received FDA approval for the Tecnis Synergy and Tecnis Synergy Toric II intraocular lenses (IOLs), aimed at improving outcomes for cataract patients. Similarly, in April 2021, Alcon Canada launched several presbyopia-correcting lenses, including the AcrySof® IQ PanOptix® UV IOL, AcrySof® IQ PanOptix® Toric UV IOL, AcrySof® IQ Vivity® UV IOL, and AcrySof® IQ Vivity® Toric UV IOL, expanding cataract treatment options for Canadian patients.

These advancements, combined with the growing need for cataract surgery devices driven by rising cataract cases and risk factors, are expected to significantly contribute to the market's growth in North America.

Cataract Surgery Devices Market Key Players:

Some of the key market players operating in the cataract surgery devices market include Alcon Inc., Johnson & Johnson Services, Inc., NIDEK CO., LTD., ZEISS Group, Bausch Health Companies Inc., Ziemer Ophthalmic Systems AG, Abbott Laboratories, HOYA Corporation, Aurolab, Hanita Lenses Ltd, Topcon Corporation, STAAR SURGICAL, Bohus BioTech AB, Eyekon Medical, CIMA Technology Inc., Medisonic Equipments Pvt. Ltd., Opthalmika Ltd, Lumenis Be Ltd., Essilor International, Oertli Instrumente AG, and others.

Recent Developmental Activities in the Cataract Surgery Devices Market:

• In July 2024, Oertli Instrumente AG announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Faros anterior cataract surgery system. It is a high-performance surgical platform designed for cataract, vitreoretinal, and glaucoma procedures. Its advanced fluid and vacuum control capabilities provide advanced precision, allowing it to adapt seamlessly to varying cataract hardness levels.
• In June 2024, Alcon received U.S. Food and Drug Administration (FDA) 510(k) clearance for UNITY® Vitreoretinal Cataract System (VCS) and UNITY® Cataract System (CS). This system is developed to offer enhanced precision for vitreoretinal procedures in cataract surgery.
• In April 2023, Bausch + Lomb Corporation launched the StableViscTM cohesive ophthalmic viscosurgical device (OVD) as well as the TotalViscTM Viscoelastic System in the United States. These devices are designed to maintain space in the anterior chamber of the eye. This facilitates the effective extraction and replacement of the clouded natural lens during cataract surgery.

Key Takeaways from the Cataract Surgery Devices Market Report Study

• Market size analysis for current Cataract Surgery Devices Market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the Cataract Surgery Devices market.
• Various opportunities available for the other competitors in the Cataract Surgery Devices Market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current Cataract Surgery Devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Cataract Surgery Devices market growth in the coming future?

Target Audience who can be benefited from this Cataract Surgery Devices Market Report Study

• Cataract Surgery Devices product providers
• Research organizations and consulting companies
• Cataract Surgery Devices related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Cataract Surgery Devices
• Various end-users who want to know more about the Cataract Surgery Devices Market and the latest technological developments in the Cataract Surgery Devices Market.

Frequently Asked Questions for the Cataract Surgery Devices Market:

1. What are Cataract Surgery Devices?

Cataract surgery devices are medical devices that are employed during cataract surgery and carry out tasks in different steps during the surgery such as breaking the cataract into small pieces which are performed by phacoemulsification devices and the replacement by artificial lenses such as intraocular lenses among other products.

2. What is the market for Cataract Surgery Devices?

The Cataract Surgery Devices Market was valued at USD 7.73 billion in 2023, growing at a CAGR of 5.50% during the forecast period from 2024 to 2030 to reach USD 10.66 billion by 2030.

3. What are the drivers for the Cataract Surgery Devices market?

The cataract surgery devices market is slated to witness prosperity owing to factors such as the growing prevalence of cataracts and vision impairment and the increasing prevalence of lifestyle disorders that develop cataracts such as hypertension and diabetes. The rising geriatric population and R&D activities and technological innovation in product development are some of the key factors resulting in appreciable revenue growth in the Cataract Surgery Devices Market during the forecast period (2024 to 2030).

4. Who are the key players operating in the Cataract Surgery Devices market?

Some of the key market players operating in the cataract surgery devices market include Alcon Inc., Johnson & Johnson Services, Inc., NIDEK CO., LTD., ZEISS Group, Bausch Health Companies Inc., Ziemer Ophthalmic Systems AG, Abbott Laboratories, HOYA Corporation, Aurolab, Hanita Lenses Ltd, Topcon Corporation, STAAR SURGICAL, Bohus BioTech AB, Eyekon Medical, CIMA Technology Inc., Medisonic Equipments Pvt. Ltd., Opthalmika Ltd, Lumenis Be Ltd., Essilor International, Oertli Instrumente AG, and others.

5. Which region has the highest share in the Cataract Surgery Devices market?

North America is expected to account for the largest share in the cataract surgery devices market in 2023, among all the regions. This is attributed to the rising prevalence of cataracts and vision impairments in the region coupled with increasing prevalence of risk factors such as diabetes, hypertension, and obesity. The growing aging population which is more prone to develop cataracts and technological innovation in the product development in the region are some of the key factors driving the growth of the cataract surgery devices market in North America.